Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
This week, I have an announcement to make.
Find out more at
https://LifeScienceTodayPodcast.com
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to bio...
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Sanofi/Takeda
UniQure & CSL
Fog Pharma
Merck + Imago
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new te...
A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Indivior + Opiant
Regeneron + CytomX
Rezo
Provention
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharm...
More CRISPR data, oncology wins, and a new player in ophthalmology
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Intellia
Regeneron
Viatris + Oyster Point
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, ne...
Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Sumitovant + Myovant
Thermo Fisher + Binding Site Group
Astellas & Taysha
Agios
Vaxctye
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. ...
Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
FDA
AbbVie + DJS
Roche + Hookipa
Kyverna
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, ...
One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news
Find out more at
https://LifeScienceTodayPodcast.com
Story References
DICE
Odyssey
Fred Hutch
Merck (MSD), Merck Story 2
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights ab...
Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Nested Therapeutics
Cellarity
Replimune
Estrella Biopharma
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights abou...
Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Eisai + Biogen
Amylyx
Sanofi + Regeneron
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and ...
A $900 raise, gene therapy news, a quick IPO, and merge three for $100M
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Alnylam, Link 2, Link 3
Intellia Therapeutics
Third Harmonic Bio
Galvanize Therapeutics
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new te...
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Revance
Velocity + MedPharmics
Arsenal
SpringWorks Link 1, Link 2, Link 3
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expe...
A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Novo + Forma
Sanofi
Boehringer Ingelheim
Arcturus
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers...
Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Alcon + Aerie
Novartis + Sandoz
Labcorp + RWJBH
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new tec...
Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Bluebird
Endo & Pharmacies
Genentech + Jemincare
Merck + Orna
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new techno...
Spending that COVID money, brain money, Irish money, and another oncology approval.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Pfizer
Cerevel
Abbott
AstraZeneca + Daiichi Sankyo
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutic...
This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives?
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Zymergen + Ginkgo
Cassava
Teva
About the Show
Life Science Today is your source for stories, insights, and tre...
There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two As
Find out more at
https://LifeScienceTodayPodcast.com
Story References
ZyVersa
Incyte
Revolution
Frontera
CAMP4
ForSight
Auron
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, ph...
Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Vertex + ViaCyte
Theravance Biopharma
Merck + Orion
Pliant Therapeutics
Qiming
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expe...
FEED DROP - Clinical Research Evolved
Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth.
Find Out More
Dan Agroskin
Clinical Research Evolved
Noah Goodson, PhD
Double acquisition, private money, affordable deals, and a surprising $70M launch
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Galapagos + CellPoint + AboundBio
Radius
Ipsen + Epizyme
DEM Bio
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, ...
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
If you can never get enough true crime... Congratulations, you’ve found your people.
NFL.com's "Around the NFL" crew (Gregg Rosenthal, Dan Hanzus and Marc Sessler) break down the latest football news, with a dash of mirth.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Listen to 'The Bobby Bones Show' by downloading the daily full replay.